enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. BrightFocus Foundation - Wikipedia

   en.wikipedia.org/wiki/BrightFocus_Foundation

   BrightFocus Foundation is a nonprofit organization based in Clarksburg, Maryland.BrightFocus funds research in an effort to discover cures for Alzheimer's disease, macular degeneration and glaucoma, and provides information and free English and Spanish resources to increase awareness about these diseases.

3. Stem cell therapy for macular degeneration - Wikipedia

   en.wikipedia.org/wiki/Stem_cell_therapy_for...

   Induced pluripotent stem cell taken from blood cell and converted in retinal pigment epithelium. Stem cell therapy for macular degeneration is an emerging treatment approach aimed at restoring vision in individuals suffering from various forms of macular degeneration, particularly age-related macular degeneration (AMD). [1]

4. Macular degeneration - Wikipedia

   en.wikipedia.org/wiki/Macular_degeneration

   The incidence of age-related macular degeneration and its associated features increases with age and is low in people <55 years of age. [101] Smoking is the strongest modifiable risk factor. [102] As of 2008, age-related macular degeneration accounts for more than 54% of all vision loss in the white population in the US. [103]

5. SENS Research Foundation - Wikipedia

   en.wikipedia.org/wiki/SENS_Research_Foundation

   Ichor Therapeutics is developing repair therapy for macular degeneration. [22] Underdog Pharmaceuticals received an Innovation Passport, an accelerated regulatory pathway from the UK government for promising therapies, for a small molecule drug to treat atherosclerosis by clearing arterial plaques. [23]

6. National Eye Institute - Wikipedia

   en.wikipedia.org/wiki/National_Eye_Institute

   Comparison of Age-Related Macular Degeneration Treatments Trial: Lucentis-Avastin Trial: This two-year, multicenter clinical trial compared the effectiveness of two treatments used for AMD: Lucentis and Avastin. It showed that both treatments are equally effective in treating AMD and improving vision, whether used monthly or as needed.

7. Astellas Institute for Regenerative Medicine - Wikipedia

   en.wikipedia.org/wiki/Astellas_Institute_for...

   On November 30, 2010, Ocata filed an Investigational New Drug application with the U.S. FDA for the first clinical trial using embryonic stem cells to regenerate retinal pigment epithelium to treat Dry Age-Related Macular Degeneration (Dry AMD). [17]